04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Source Url: https://www.jdsupra.com/legalnews/hhs-gives-new-guidance-on-drug-21788/
Related
Evolution Capital Partners has acquired Health Technologies, according to a news release. Health Te...
Read More >
There is a lot of confusion about how the California Consumer Privacy Act (CCPA) will impact Califor...
Read More >
On October 10, 2019, the National Labor Relations Board issued an important decision in LA Specialty...
Read More >
When an employee reports a concern regarding fraudulent or illegal behavior, an employer’s immediat...
Read More >
The market for CBD products is booming. People are using CBD to treat various health conditions, suc...
Read More >
Don't take "don't guess" too literally. One bit of very standard advice that all attorneys give to ...
Read More >